Back
Lineage Cell Therapeutics, Inc. Stock Price Chart
Safe Investing Checklist - Stay Clear of Risky Stocks
Get Your Free Safe Stock Selector Checklist Now
Sell
36
LCTX
Lineage Cell Therapeutics, Inc.
Last Price:
$1.71
Seasonality Move:
11.05%
7 Day Trial
ALL ACCESS PASS
$
7
Get Your Free Stock Selector Checklist and Invest Smarter
Get Your Free Safe Stock Selector Checklist Now-
The current trend is relatively stagnant and LCTX is experiencing slight selling pressure.
Lineage Cell Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.7 | Buy |
| 20-day SMA: | 1.75 | Sell |
| 50-day SMA: | 1.74 | Sell |
| 200-day SMA: | 1.04 | Buy |
| 8-day EMA: | 1.71 | Buy |
| 20-day EMA: | 1.72 | Buy |
| 50-day EMA: | 1.48 | Buy |
| 200-day EMA: | 0.65 | Buy |
Lineage Cell Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 49.51 | Sell |
| Chaikin Money Flow: | -170805 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.69 - 1.85) | Sell |
| Bollinger Bands (100): | (1.16 - 1.78) | Buy |
Lineage Cell Therapeutics, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Lineage Cell Therapeutics, Inc. Stock
Is Lineage Cell Therapeutics, Inc. Stock a Buy?
-
Lineage Cell Therapeutics, Inc. share price is 1.72 while LCTX 8-day simple moving average is 1.70, which is a Buy signal.
-
The stock price of LCTX is 1.72 while Lineage Cell Therapeutics, Inc. 20-day SMA is 1.75, which makes it a Sell.
-
Lineage Cell Therapeutics, Inc. 50-day simple moving average is 1.74 while LCTX share price is 1.72, making it a Sell technically.
-
LCTX stock price is 1.72 and Lineage Cell Therapeutics, Inc. 200-day simple moving average is 1.04, creating a Buy signal.
LCTX Technical Analysis vs Fundamental Analysis
Sell
36
Lineage Cell Therapeutics, Inc. (LCTX)
is a Sell
Is Lineage Cell Therapeutics, Inc. a Buy or a Sell?
-
Lineage Cell Therapeutics, Inc. stock is rated a SellThe current Lineage Cell Therapeutics, Inc. [LCTX] share price is $1.72. The Score for LCTX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Lineage Cell Therapeutics, Inc. Stock Info
Market Cap:
396.2M
Price in USD:
1.72
Share Volume:
854K
Lineage Cell Therapeutics, Inc. 52-Week Range
52-Week High:
2.09
52-Week Low:
0.37
Sell
36
Lineage Cell Therapeutics, Inc. (LCTX)
is a Sell
Lineage Cell Therapeutics, Inc. Share Price Forecast
-
What is the Lineage Cell Therapeutics, Inc. stock price today?The Lineage Cell Therapeutics, Inc. stock price is 1.72 USD today.
-
Will LCTX stock go up or go down?Lineage Cell Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Lineage Cell Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Lineage Cell Therapeutics, Inc. is overvalued.
Is Lineage Cell Therapeutics, Inc. Stock a Buy?
-
Lineage Cell Therapeutics, Inc. share price is 1.72 while LCTX 8-day exponential moving average is 1.71, which is a Buy signal.
-
The stock price of LCTX is 1.72 while Lineage Cell Therapeutics, Inc. 20-day EMA is 1.72, which makes it a Buy.
-
Lineage Cell Therapeutics, Inc. 50-day exponential moving average is 1.48 while LCTX share price is 1.72, making it a Buy technically.
-
LCTX stock price is 1.72 and Lineage Cell Therapeutics, Inc. 200-day simple moving average is 0.65, creating a Buy signal.
Fundamental Analysis of Lineage Cell Therapeutics, Inc.
Is Lineage Cell Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and an increase next year of $0.23 per share.
Technical Analysis of Lineage Cell Therapeutics, Inc.
Should I short Lineage Cell Therapeutics, Inc. stock?
-
LCTX Moving Average Covergence Divergence (MACD) indicator is 0.03, suggesting Lineage Cell Therapeutics, Inc. is a Buy
-
Lineage Cell Therapeutics, Inc. Relative Strength Index (RSI) is 49.51, which suggest Lineage Cell Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Lineage Cell Therapeutics, Inc. is (1.69 - 1.85), which suggest Lineage Cell Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Lineage Cell Therapeutics, Inc. is (1.16 - 1.78), which suggest Lineage Cell Therapeutics, Inc. is a Buy
* Lineage Cell Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.